Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
hoops's Profile
Displaying 101-150 of 1350 result(s).
CYDY CytoDyn Inc
01/24/2025 2:52:01 PM
Just turned green. (1)
CYDY CytoDyn Inc
01/24/2025 10:56:15 AM
For what it's worth, today's "sell- (8)
CYDY CytoDyn Inc
01/23/2025 10:06:16 AM
Here come the trades.
CYDY CytoDyn Inc
01/23/2025 8:39:12 AM
Is institutional ownership of stock (4)
CYDY CytoDyn Inc
01/22/2025 4:40:43 PM
Don't know if this has been posted. (2)
CYDY CytoDyn Inc
01/22/2025 11:51:13 AM
Can anyone see the size of the lots
CYDY CytoDyn Inc
01/22/2025 10:21:50 AM
1M shares traded during the first 5 (2)
CYDY CytoDyn Inc
01/22/2025 9:47:05 AM
Spread of more than .01 between bid
CYDY CytoDyn Inc
01/22/2025 9:07:43 AM
Up .02 on 8.5K shares. Is that a T-
CYDY CytoDyn Inc
01/21/2025 3:32:01 PM
Are you guys buying again, or does (1)
CYDY CytoDyn Inc
01/10/2025 4:11:14 PM
Up 18% on 4.7M shares. Nice volume. (3)
CYDY CytoDyn Inc
01/10/2025 1:01:19 PM
Correction: Up 15% on 3M shares wit
CYDY CytoDyn Inc
01/10/2025 12:40:53 PM
Up 18.5% on 2.3M shares with 3 hour (3)
CYDY CytoDyn Inc
01/08/2025 6:21:43 AM
I hadn't thought of the Amarex sett (4)
CYDY CytoDyn Inc
01/07/2025 8:42:26 AM
Thanks, cd. It certainly is somethi (1)
CYDY CytoDyn Inc
01/07/2025 7:23:19 AM
Do we know when the second Amarex p
CYDY CytoDyn Inc
12/17/2024 12:36:24 PM
VANCOUVER, Washington, July 09, 202 (11)
CYDY CytoDyn Inc
12/04/2024 9:30:30 AM
The only opinion that matters here (10)
CYDY CytoDyn Inc
11/20/2024 1:37:24 PM
"As shareholders, you remain the li (11)
CYDY CytoDyn Inc
11/05/2024 10:01:03 AM
OT: After owning a Roth IRA for 5 y
CYDY CytoDyn Inc
11/04/2024 8:54:30 AM
“We have appreciated the opportu (8)
CYDY CytoDyn Inc
10/31/2024 10:44:03 AM
Just an observation. This market is (5)
CYDY CytoDyn Inc
10/31/2024 9:55:33 AM
They aren't on my Iphone either.
CYDY CytoDyn Inc
10/30/2024 12:38:53 PM
Today’s PR is the fourth this mon (12)
CYDY CytoDyn Inc
10/11/2024 3:38:56 PM
Up 10.4% on volume of 4M shares. I (3)
CYDY CytoDyn Inc
10/10/2024 12:04:52 PM
You’re right. I meant to say 9 ye (1)
CYDY CytoDyn Inc
10/10/2024 11:42:36 AM
Could this be one of those early mo
CYDY CytoDyn Inc
10/10/2024 11:19:39 AM
Obviously, that's HIV.
CYDY CytoDyn Inc
10/10/2024 10:27:03 AM
Thanks Buck. The single trade is th (1)
CYDY CytoDyn Inc
10/10/2024 10:08:45 AM
Schwab still showing 1.2M shares tr
CYDY CytoDyn Inc
10/10/2024 9:44:16 AM
I don't have level II. Was that one
CYDY CytoDyn Inc
10/10/2024 9:34:51 AM
1.2M shares traded already?
CYDY CytoDyn Inc
10/08/2024 6:23:15 AM
inflammaging? https://www.healthlin (2)
CYDY CytoDyn Inc
09/25/2024 9:28:24 AM
Can leronlimab serve as the standar (4)
CYDY CytoDyn Inc
09/24/2024 10:49:24 AM
Did I misread something? Leronlimab (5)
CYDY CytoDyn Inc
09/24/2024 10:34:33 AM
All three studies used 700 mg leron (5)
CYDY CytoDyn Inc
09/11/2024 10:45:07 AM
Thanks.
CYDY CytoDyn Inc
09/11/2024 8:03:33 AM
Is there any way to stop those drop (3)
CYDY CytoDyn Inc
09/09/2024 3:50:01 PM
That's the point I was trying to ma (2)
CYDY CytoDyn Inc
09/05/2024 12:50:34 PM
I didn’t even finish a follow up, (7)
CYDY CytoDyn Inc
09/05/2024 11:38:24 AM
No news on the Cytodyn website. Eit (9)
CYDY CytoDyn Inc
08/12/2024 9:12:11 AM
It's good to see the focus on oncol (1)
CYDY CytoDyn Inc
08/12/2024 8:44:00 AM
" Advancing leronlimab in the oncol (2)
CYDY CytoDyn Inc
08/12/2024 8:42:49 AM
https://www.cytodyn.com/newsroom/p (3)
CYDY CytoDyn Inc
07/26/2024 1:02:22 PM
https://www.cbsnews.com/news/andre (14)
CYDY CytoDyn Inc
07/19/2024 6:45:08 AM
https://www.sciencedaily.com/relea (1)
CYDY CytoDyn Inc
07/11/2024 8:44:34 AM
I should have given credit to the e (6)
CYDY CytoDyn Inc
07/11/2024 8:13:08 AM
Since becoming interim CEO 0n 11/21 (38)
CYDY CytoDyn Inc
07/09/2024 2:15:02 PM
It goes without saying, but I’ll (1)
CYDY CytoDyn Inc
07/09/2024 10:21:13 AM
I would think that SA told Cytodyn (6)
Go to page:
  • << First
  • < Previous
  • 2
  • 3
  • Next >

Recent Articles

  • Reddit Investors: Join the Class Action Against Fraud Today
  • Investor Alert: Securities Fraud Class Action Lawsuit Against Hims & Hers
  • Perplexity's Success: Aravind Srinivas Challenges Tech Titans
  • Insights from Bill Ackman: Investing During Market Uncertainty
  • Berkshire Hathaway Faces Challenges Amidst Market Uncertainty
  • Unveiling Underrated Stocks to Watch for Future Growth
  • Revolutionizing Connectivity: The Future of Starlink Technology
  • Understanding Your Rights as a Simulations Plus, Inc. Investor
  • Shiba Inu Coin Flourishes as HashJ Introduces New Contracts
  • Recent Stock Insights: Key Players in the Market Breakdown
  • Risetcar's Autonomous Taxis Set to Transform Jakarta's Transport
  • Pan-Mass Challenge: Cyclists Unite for Groundbreaking Research
  • Bitcoin Swift Presale Enters New Phase with Innovative AI Rewards
  • Celebrating Financial Health: Global Impact Champions Awards Launch
  • Avast Emerges as the Top Choice for Antivirus Software
  • FAA Implements Changes to Helicopter Routes after Tragedy
  • Navigating High-Beta Stocks: Echoes of the Dot-Com Boom
  • Understanding the Real Dynamics Behind Portfolio Performance
  • Overview of Financière de Tubize’s Half-Year Performance
  • Financière de Tubize Unveils Promising Financial Results for 2025
  • Legal Actions from Shareholders: Insights on Sarepta and Petco
  • Kuvi.ai Unveils Agentic Finance OS in Seed Funding Expansion
  • SHARC Energy Advancing Financing with New Convertible Debentures
  • Important Class Action Update for Hims & Hers Health Investors
  • Class Action Lawsuit Emerges Against Flywire Corporation
  • Important Update for Sable Offshore Investors: Act Now
  • Class Action Notice for Neogen Investors: Key Details Inside
  • Tempus AI Faces Legal Challenges Following SEC Allegations
  • Replimune Group Faces Class Action: Key Insights for Investors
  • Neogen Corporation Investors Can Join Class Action Efforts
  • Key Actions for Luminar Technologies Investors Amid Class Action
  • Investors Urged to Act: RxSight Class Action Deadline Approaches
  • Sable Offshore Corp. Class Action: Important Actions for Investors
  • Protecting Your Rights Following Securities Claims with TRSG
  • Investors of Fiserv, Inc. Can Join Class Action for Losses
  • Kepler's K2 Humanoid Robot Revolutionizes Industrial Automation
  • Investor Rights Firm Investigates Potential Mergers and Sales
  • Investigating Stockholder Rights: Olo, Fubo, Arcadia, and Norfolk
  • RxSight Inc. Faces Class Action Lawsuit Over Misleading Claims
  • Spitzer Autoworld Elevates Customer Experience with New VIP Program
  • HashJ Launches New BTC Participation Contracts Amid Market Shift
  • Experience Vibrant Music Events at Great Park Live This Season
  • Explore OLIVE YOUNG's K-Beauty Innovations at KCON LA 2025
  • Discovering the Exceptional Growth of Gartner Stock Today
  • Investors of Sable Offshore Corp. Encouraged to File Claims
  • Senate Bill Secures Funding for OSHA and NIOSH - A Win for Safety
  • Arteris, Inc. Boosts Team with New Inducement Stock Awards
  • Investing in Ameriprise Financial: A 5-Year Review
  • Grupo Cox Makes Major Investment with Iberdrola Acquisition
  • First National Bank Alaska Announces Strong Q3 Dividend Strategy
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site